According to GuruFocus Insider Data, these are the largest insider sells during the past week. The overall trend of insiders is illustrated in the chart below:
Regeneron Pharmaceuticals, Inc. (REGN, Financial): SVP Finance and Admin CFO and Murray A Goldberg sold 66,835 Shares
SVP Finance and Admin CFO and of Regeneron Pharmaceuticals, Inc. (REGN) Murray A Goldberg sold 66,835 shares on 05/21/2013 at an average price of $250.31. Regeneron Pharmaceuticals, Inc. was incorporated in January 1988 in the State of New York. Regeneron Pharmaceuticals, Inc. has a market cap of $24.97 billion; its shares were traded at around $250.31 with a P/E ratio of 34.60 and P/S ratio of 19.37.
On May 3, 2013 Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2013 and provided an update on development programs. The Company reported total revenues of$440 million in the first quarter of 2013, compared to$232 million in the first quarter of 2012. Total revenues include EYLEA U.S. net product sales of$314 million in the first quarter of 2013, compared to$124 million in the first quarter of 2012. The Company reported non-GAAP net income of$201 million, or$1.78 per diluted share, in the first quarter of 2013, compared to$40 million, or$0.37 per diluted share, in the first quarter of 2012. Non-GAAP net income excludes non-cash share-based compensation expense, non-cash interest expense related to the Company's convertible senior notes, and non-cash income taxes. The Company reported GAAP net income of$99 million, or$0.90 per diluted share, in the first quarter of 2013, compared to$12 million, or$0.11 per diluted share, in the first quarter of 2012.
SVP Commercial Robert J Terifay sold 8,231 shares of REGN stock on 05/08/2013 at the average price of 261.23. Robert J Terifay owns at least 16,912 shares after this. The price of the stock has decreased by 4.18% since.
For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.
Regeneron Pharmaceuticals, Inc. (REGN, Financial): SVP Finance and Admin CFO and Murray A Goldberg sold 66,835 Shares
SVP Finance and Admin CFO and of Regeneron Pharmaceuticals, Inc. (REGN) Murray A Goldberg sold 66,835 shares on 05/21/2013 at an average price of $250.31. Regeneron Pharmaceuticals, Inc. was incorporated in January 1988 in the State of New York. Regeneron Pharmaceuticals, Inc. has a market cap of $24.97 billion; its shares were traded at around $250.31 with a P/E ratio of 34.60 and P/S ratio of 19.37.
On May 3, 2013 Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2013 and provided an update on development programs. The Company reported total revenues of$440 million in the first quarter of 2013, compared to$232 million in the first quarter of 2012. Total revenues include EYLEA U.S. net product sales of$314 million in the first quarter of 2013, compared to$124 million in the first quarter of 2012. The Company reported non-GAAP net income of$201 million, or$1.78 per diluted share, in the first quarter of 2013, compared to$40 million, or$0.37 per diluted share, in the first quarter of 2012. Non-GAAP net income excludes non-cash share-based compensation expense, non-cash interest expense related to the Company's convertible senior notes, and non-cash income taxes. The Company reported GAAP net income of$99 million, or$0.90 per diluted share, in the first quarter of 2013, compared to$12 million, or$0.11 per diluted share, in the first quarter of 2012.
SVP Commercial Robert J Terifay sold 8,231 shares of REGN stock on 05/08/2013 at the average price of 261.23. Robert J Terifay owns at least 16,912 shares after this. The price of the stock has decreased by 4.18% since.
For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.
